CircRNA DLGAP4 was also reported to have protective effects in diabetic kidney disease progression, myocardial ischemia–reperfusion injury, and Parkinson's disease, all by regulating the most probable target, miR‐143, but different downstream target genes.16, 17, 18. This evidence concerns the gene DLGAP4 and Parkinson disease.